Insperity Q1 net income falls 35% as revenue rises 3%; updates 2025 guidance
Insperity reported first-quarter 2025 results and updated its 2025 outlook. Revenues rose 3% to $1.9 billion, but net income fell 35% to $51 million, driven by higher-than-expected healthcare costs. The updated full-year guidance projects adjusted EPS of $2.23 to $3.28, a year-over-year decrease of 8% to 38%, which points to lower earnings for shareholders in 2025.
Key points
- Q1 2025 net income was $51 million, down 35% from $79 million; diluted EPS was $1.35 versus $2.08 a year earlier.
- Revenues rose 3% to $1.9 billion, but gross profit fell 10% to $310 million on higher-than-expected benefits costs.
- Full-year 2025 guidance: adjusted EPS of $2.23 to $3.28 and adjusted EBITDA of $190 million to $245 million, both down year over year.
- Q2 2025 adjusted EPS guidance is $0.29 to $0.67, a year-over-year decrease of 66% to 22%.
The filing
Written by AI on Nov 8, 2026, 1:55 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 29, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.